It is our goal to advance research and clinical applications by providing routine, accurate, cost-effective analysis of genomic structural information.
Nabsys is the pioneer in electronic whole-genome mapping, and provides high-resolution, long-range genomic information using solid-state semiconductor-based nanodetectors.
The HD-Mapping™ platform is a complete whole-genome mapping solution, providing fully- integrated instrumentation, nanodetector chips, protocols, reagents, and analytical software. HD-Mapping detects and characterizes complex genomic structural variants (SVs) and complements all existing NGS methodologies for single nucleotide variants (SNV) analysis, by providing genomic structural information (inserts, deletions, inversions, repeat regions) not available with short-read technologies.
HD-Mapping enables a wide variety of key applications across Genomic, Cytogenomic, Metagenomic, Agbio, and Industrial markets.
Nabsys is a privately-held company founded in 2005 and headquartered in Providence, Rhode Island, USA.
Nabsys 60 Clifford Street Providence, Rhode Island, 02903 USA
Nabsys develops semiconductor-based tools for genomic analysis that are capable of analyzing entire genomes in very large fragments.